Keratin 9 (KRT9) (Middle Region) Peptide
KRT9
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits KRT9
- KRT9 (Keratin 9 (KRT9))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- LEKEIETYHN LLEGGQEDFE SSGAGKIGLG GRGGSGGSYG RGSRGGSGGS
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- KRT9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- KRT9 (Keratin 9 (KRT9))
- Synonymes
- CK-9 Peptide, EPPK Peptide, K9 Peptide, Krt1-9 Peptide, keratin 9 Peptide, KRT9 Peptide, Krt9 Peptide
- Sujet
-
This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma.
Alias Symbols: K9, CK-9, EPPK
Protein Size: 623 - ID gène
- 3857
- NCBI Accession
- NM_000226, NP_000217
- UniProt
- P35527
-
Vous êtes ici:
